ConductScience.org, home

Gene · 1128

Papers1,761

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Short-term outcomes of a refined duodenal LECS technique: A single-center retrospective series.Surg Oncol202642815342PubTator, text miningPubMed
Structural basis for broad orthopoxvirus neutralization by two antibodies targeting distinct L1R epitopes.Cell Rep Med202642805179PubTator, text miningPubMed
GPCR-Driven Muscarinic M1 and Histamine H1 Receptor Signaling Converging on the PI3K/Akt/mTOR Pathway: Functional Integration in Neuroinflammation and Myelin Repair in Multiple Sclerosis.Mol Neurobiol202642714765PubTator, text miningPubMed
From human dental pulp stem cells to functional cholinergic neurons: An optimized neurogenic differentiation protocol for new approach methodologies.J Dent Sci202642688638PubTator, text miningPubMed
Machine learning-assisted design of a dendritic cell nanovaccine inducing twin immunity against monkeypox.J Control Release202642660460PubTator, text miningPubMed
TDP-43 promotes allergen-induced inflammation and influenza A virus replication in airway epithelium.Nat Commun202642642428PubTator, text miningPubMed
Mapping Trofinetide Polypharmacology in Rett Syndrome: A Multi-Stage Computational Analysis.J Comput Chem202642530159PubTator, text miningPubMed
Functional insights into autoantibodies targeting muscarinic acetylcholine receptors in Sjögren's disease.Ann Rheum Dis202642425798PubTator, text miningPubMed
An integrated review of monkeypox: from pathogen and epidemiology to diagnostics, control, and challenges.Emerg Microbes Infect202642410978PubTator, text miningPubMed
Low Agonism and Balanced Pathway Modulation Distinguish an M1 Muscarinic Receptor Positive Allosteric Modulator Lacking Cholinergic Adverse Effects.ACS Chem Neurosci202642376914PubTator, text miningPubMed
Structure-based prediction of muscarinic M1/M3 receptor antagonist activity: Curated dataset and scaffold-aware evaluation.J Pharmacol Exp Ther202642308581PubTator, text miningPubMed
Integrating network toxicology, machine learning, and single-cell sequencing to reveal the FASN-mediated role of phenolic endocrine disruptors in water in promoting prostate cancer.PLoS One202642228706PubTator, text miningPubMed
Integrative multi-omics and network analysis identify potential targets of Chaihu Shugan Xiaozheng Formula in breast cancer.Transl Oncol202642184719PubTator, text miningPubMed
Investigating the Impact of Bisphenol A on Gastric Cancer Through Network Toxicology and Molecular Docking.Int J Toxicol202642134865PubTator, text miningPubMed
Deciphering the anxiolytic mechanism of glycowithenolides from Withania somnifera: insights from network pharmacology, molecular docking, and simulation studies.In Silico Pharmacol202642130673PubTator, text miningPubMed
Dequalinium-based bitopic ligands uncover distinct pharmacological modulation of muscarinic receptors.Biochem Pharmacol202642061623PubTator, text miningPubMed
Functional Evaluation of Tetrahydroisoquinoline-Derived Ligands Reveals Distinct Modulatory Profiles at the Muscarinic M1 Receptor.ACS Med Chem Lett202641982714PubTator, text miningPubMed
Antimuscarinic drugs exert β-arrestin-biased agonism at the muscarinic acetylcholine type 1 receptor to promote DRG neuritogenesis.Sci Signal202641915732PubTator, text miningPubMed
Transcriptional and functional profiles of muscarinic receptor-expressing neurons in primate lateral prefrontal and anterior cingulate cortices.Commun Biol202641857244PubTator, text miningPubMed
TBXA2R activates ERMs to drive motility, invasion, and metastatic colonization of TNBC cells.Life Sci Alliance202641844278PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/1128/papers